SCHEDULES
SCHEDULE 2 Controlled Drugs
Part I Class A Drugs
1
The following substances and products, namely:—
F1a
Acetorphine.
F2Alfentanil.
Allylprodine.
Alphacetylmethadol.
Alphameprodine.
Alphamethadol.
Alphaprodine.
Anileridine.
Benzethidine.
Benzylmorphine (3-benzylmorphine).
Betacetylmethadol.
Betameprodine.
Betamethadol.
Betaprodine.
Bezitramide.
F147Brorphine.
Bufotenine.
F148Butonitazene.
F45...
F46...
F3Carfentanil.
Clonitazene.
Coca leaf.
Cocaine.
Desomorphine.
Dextromoramide.
Diamorphine.
Diampromide.
Diethylthiambutene.
F4Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).
DihydrocodeinoneO-carboxymethyloxime.
F40Dihydroetorphine
Dimenoxadole.
Dimepheptanol.
Dimethylthiambutene.
Dioxaphetyl butyrate.
Diphenoxylate.
Dipipanone.
F5Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).
Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.
F149Ethyleneoxynitazene.
Ethylmethylthiambutene.
F2Eticyclidine.
F150Etodesnitazene (etazene).
Etonitazene.
Etorphine.
Etoxeridine.
F6Etryptamine
Fentanyl.
F151Flunitazene.
F48Fungus (of any kind) which contains psilocin or an ester of psilocin.
Furethidine.
Hydrocodone.
Hydromorphinol.
Hydromorphone.
Hydroxypethidine.
Isomethadone.
F152Isotonitazene.
Ketobemidone.
Levomethorphan.
Levomoramide.
Levophenacylmorphan.
Levorphanol.
F3Lofentanil
Lysergamide.
Lysergide and otherN-alkyl derivatives of lysergamide.
Mescaline.
Metazocine.
Methadone.
Methadyl acetate.
F49Methylamphetamine
Methyldesorphine.
Methyldihydromorphine (6-methyldihydromorphine).
F153Metodesnitazene (metazene).
Metonitazene.
Metopon.
Morpheridine.
Morphine.
Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.
Myrophine.
F7...
Nicomorphine (3,6-dinicotinoylmorphine).
Noracymethadol.
Norlevorphanol.
Normethadone.
Normorphine.
Norpipanone.
Opium, whether raw, prepared or medicinal.
Oxycodone.
Oxymorphone.
Pethidine.
Phenadoxone.
Phenampromide.
Phenazocine.
F8Phencyclidine.
Phenomorphan.
Phenoperidine.
Piminodine.
Piritramide.
Poppy-straw and concentrate of poppy-straw.
Proheptazine.
Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).
F154Protonitazene.
Psilocin.
Racemethorphan.
Racemoramide.
Racemorphan.
F41Remifentanil
F2Rolicyclidine.
F9Sufentanil.
F80Tapentadol.
F2Tenocylidine.
Thebacon.
Thebaine.
F9Tilidate.
Trimeperidine.
F100(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52).
F104-Bromo-2,5-dimethoxy-a-methylphenethylamine.
4-Cyano-2-dimethylamino-4,4-diphenylbutane.
4-Cyano-1-methyl-4-phenyl-piperidine.
F1071-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).
F155N-Desethyl etonitazene.
N-Desethylisotonitazene.
N-Desethyl protonitazene.
F1013,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921);
F1093,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700).
F117(6aR,9R) R,9 R)- N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD);
(6aR,9R) R,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD);
(6aR,9R)R,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD).
N,N-Diethyltryptamine.
F1022,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg]quinolin-9-yl}methanone (LSZ).
N,N-Dimethyltryptamine.
2,5-Dimethoxy-a,4-dimethylphenethylamine.
F11N-Hydroxy-tenamphetamine.
1-Methyl-4-phenylpiperidine-4-carboxylic acid.
2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.
F124-Methyl-aminorex
F1084-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR).
4-Phenylpiperidine-4-carboxylic acid ethyl ester.
F156N-Piperidinyl-etonitazene (etonitazepipne).
N-Pyrrolidino-etonitazene (etonitazepyne).
N-Pyrrolidino protonitazene.
F103b
any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say—
i
by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;
ii
by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
iii
by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;
iv
by substitution at the 2-position of the tryptamine ring system with an alkyl substituent;
F14ba
the following phenethylamine derivatives, namely:—
Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
2-Amino-1-(3,4-dimethoxyphenyl)ethanol
Benzyl(a-methyl-3,4-methylenedioxyphenethyl)amine
4-Bromo-b,2,5-trimethoxyphenethylamine
N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
Cyclopropylmethyl(a-methyl-3,4-methylenedioxyphenethyl)amine
2-(4,7-Dimethoxy-2,3-dihydro-1 H-indan-5-yl)ethylamine
2-(4,7-Dimethoxy-2,3-dihydro-1 H-indan-5-yl)-1-methylethylamine
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
2-(1,4-Dimethoxy-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
a, a-Dimethyl-3,4-methylenedioxyphenethylamine
a, a-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
Dimethyl(a-methyl-3,4-methylenedioxyphenethyl)amine
N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
2-Methoxyethyl(a-methyl-3,4-methylenedioxyphenethyl)amine
2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
b-Methoxy-3,4-methylenedioxyphenethylamine
1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
2-(a-Methyl-3,4-methylenedioxyphenethylamino)ethanol
a-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
N-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
O-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
a-Methyl-4-(methylthio)phenethylamine
b,3,4,5-Tetramethoxyphenethylamine
b,2,5-Trimethoxy-4-methylphenethylamine;
F13c
any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N -alkylphenethylamine,a-methylphenethylamine, an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.
F15d
any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,
i
by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;
ii
by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;
iii
by substitution in the piperidine ring with alkyl or alkenyl groups;
iv
by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;
v
by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;
vi
by replacement of the N-propionyl group by another acyl group;
e
any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,
i
by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;
ii
by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;
iii
by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;
iv
by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;
v
by formation of an N-oxide or of a quaternary base.
F97f
any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N-hydroxytenamphetamine, or a compound specified in sub-paragraph (ba) or (c) above, by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.
2
Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.
3
Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above F16not being a substance for the time being specified in Part II of this Schedule.
4
Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.
5
Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.
6
Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.
Part II Class B Drugs
1
The following substances and products, namely:—
F25a
Acetyldihydrocodeine.
Amphetamine.
F110N-Benzyl-ethylphenidate.
F1401,4-Butanediol.
F52Cannabinol
F52Cannabinol derivatives
F52Cannabis and cannabis resin
F47...
Codeine.
F157Cumyl-PeGaClone.
F17...
Dihydrocodeine.
F158Diphenidine.
Ephenidine.
Ethylmorphine (3-ethylmorphine).
F111Ethylnaphthidate.
Ethylphenidate.
F141Gamma-butyrolactone.
F18Glutethimide.
F1424-Hydroxy-n-butyric acid.
F112Isopropylphenidate (IPP or IPPD).
F90Ketamine.
F18Lefetamine.
F91Lisdexamphetamine.
F19Mecloqualone.
F19Methaqualone.
F20Methcathinone
F159Methoxyphenidine.
F113Methylmorphenate
Methylnaphthidate (HDMP-28).
F81...
F50...
F21a-Methylphenethylhydroxylamine
Methylphenidate.
F19Methylphenobarbitone.
F133N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA).
Nicocodine.
F22Nicodicodine (6-nicotinoyldihydrocodeine).
Norcodeine.
F23Pentazocine.
Phenmetrazine.
Pholcodine.
F24Propiram.
F114Propylphenidate.
F20Zipeprol
F1153,4-Dichloroethylphenidate.
3,4-Dichloromethylphenidate (3,4-DCMP).
F872-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol.
F1164-Fluoroethylphenidate.
4-Fluoromethylphenidate.
4-Methylmethylphenidate.
F78aa
Any compound (not being bupropion, cathinone, diethylpropion, pyrovalerone or a compound for the time being specified in sub–paragraph (a) above) structurally derived from 2–amino–1–phenyl–1–propanone by modification in any of the following ways, that is to say,
i
by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
ii
by substitution at the 3–position with an alkyl substituent;
iii
by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
F79ab
Any compound structurally derived from 2–aminopropan–1–one by substitution at the 1-position with any monocyclic, or fused‑polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways, that is to say,
i
by substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
ii
by substitution at the 3–position with an alkyl substituent;
iii
by substitution at the 2‑amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
F86ac
Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,
i
by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;
ii
by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;
iii
by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.
F25b
any 5,5 disubstituted barbituric acid.
F89c
[2,3–Dihydro–5–methyl–3–(4–morpholinylmethyl)pyrrolo[1, 2, 3–de]–1,4–benzoxazin–6–yl]–1–naphthalenylmethanone.
[9–Hydroxy–6–methyl–3–[5–phenylpentan–2–yl] oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl] acetate.
[9–Hydroxy–6–methyl–3–[5–phenylpentan–2–yl] oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl] acetate.
9-(Hydroxymethyl)–6, 6–dimethyl–3–(2–methyloctan–2–yl)–6a, 7, 10, 10a–tetrahydrobenzo[c]chromen–1–ol.
Any compound structurally derived from 3–(1–naphthoyl)indole, 3-(2-naphthoyl) indole, 1H–indol–3–yl–(1–naphthyl)methane or 1H-indol-3-yl-(2-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Any compound structurally derived from 3–(1–naphthoyl)pyrrole or 3-(2-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Any compound structurally derived from 1–(1–naphthylmethylene)indene or 1-(2-naphthylmethylene)indene by substitution at the 3–position of the indene ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Nabilone.
Any compound structurally derived from 3–phenylacetylindole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Any compound structurally derived from 2–(3–hydroxycyclohexyl)phenol by substitution at the 5–position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.
Any compound structurally derived from 3-benzoylindole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Any compound structurally derived from 3-(1-adamantoyl)indole or 3-(2-adamantoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent.
Any compound structurally derived from 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent.
F104ca
F136any compound (not being a compound for the time being specified in sub-paragraph (c) above) structurally related to 1-pentyl-3-(1-naphthoyl)indole (JWH-018), in that the four sub-structures, that is to say the indole ring, the pentyl substituent, the methanone linking group and the naphthyl ring, are linked together in a similar manner, whether or not any of the sub-structures have been modified, and whether or not substituted in any of the linked sub-structures with a benzyl or phenyl group and whether or not such compound is further substituted to any extent with alkyl, alkenyl, alkoxy, halide, haloalkyl or cyano substituents and, where any of the sub-structures have been modified, the modifications of the sub-structures are limited to any of the following, that is to say—
i
replacement of the indole ring with indane, indene, indazole, pyrrole, pyrazole, imidazole, benzimidazole, pyrrolo[2,3-b]pyridine, pyrrolo[3,2-c]pyridine or pyrazolo[3,4‑b]pyridine;
ii
replacement of the pentyl substituent with alkyl, alkenyl, benzyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl, 2-(4-morpholinyl)ethyl or (tetrahydropyran-4-yl)methyl;
iii
replacement of the methanone linking group with an ethanone, carboxamide, carboxylate, methylene bridge or methine group;
iv
replacement of the 1-naphthyl ring with 2-naphthyl, phenyl, benzyl, adamantyl, cycloalkyl, cycloalkylmethyl, cycloalkylethyl, bicyclo[2.2.1]heptanyl, 1,2,3,4-tetrahydronaphthyl, quinolinyl, isoquinolinyl, 1-amino-1-oxopropan-2-yl, 1‑hydroxy-1-oxopropan-2-yl, piperidinyl, morpholinyl, pyrrolidinyl, tetrahydropyranyl or piperazinyl.
d
1-Phenylcyclohexylamine or any compound (not being ketamine, tiletamine or a compound for the time being specified in paragraph 1(a) of Part 1 of this Schedule) structurally derived from 1-phenylcyclohexylamine or 2-amino-2-phenylcyclohexanone by modification in any of the following ways, that is to say,
i
by substitution at the nitrogen atom to any extent by alkyl, alkenyl or hydroxyalkyl groups, or replacement of the amino group with a 1-piperidyl, 1-pyrrolidyl or 1-azepyl group, whether or not the nitrogen containing ring is further substituted by one or more alkyl groups;
ii
by substitution in the phenyl ring to any extent by amino, alkyl, hydroxy, alkoxy or halide substituents, whether or not further substituted in the phenyl ring to any extent;
iii
by substitution in the cyclohexyl or cyclohexanone ring by one or more alkyl substituents;
iv
by replacement of the phenyl ring with a thienyl ring.
F96e
Any compound (not being a compound for the time being specified in paragraph 1(ba) of Part 1 of this Schedule) structurally derived from 1-benzofuran, 2,3-dihydro-1-benzofuran, 1H-indole, indoline, 1H-indene, or indane by substitution in the 6-membered ring with a 2-ethylamino substituent whether or not further substituted in the ring system to any extent with alkyl, alkoxy, halide or haloalkyl substituents and whether or not substituted in the ethylamino side-chain with one or more alkyl substituents.
2
Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.
F512A
3
Any salt of a substance for the time being specified in paragraph 1 F57, 2 or 2A of this Part of this Schedule.
4
Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.
Part III Class C Drugs
1
The following substances, namely:—
F26a
F118Adinazolam (1-(8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine).
F27Alprazolam.
F82Amineptine
F28Aminorex
F27Bromazepam.
F119Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).
F857-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one.
Benzphetamine.
F28Brotizolam
F29Buprenorphine
F27Camazepam.
F53...
F54...
F55...
F30Cathine.
F30Cathinone.
F1204’-Chlorodiazepam (7-Chloro-5-(4-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
F27Chlordiazepoxide.
Chlorphentermine.
F27Clobazam.
F27Clorazepic acid.
F27Clonazepam.
F121Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine).
F27Clotiazepam.
F27Cloxazolam.
F27Delorazepam.
F122Deschloroetizolam (2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine).
F31Dextropropoxyphene.
F27Diazepam.
F123Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
F32Diethylpropion.
F27Estazolam.
F27Ethchlorvynol.
F27Ethinamate.
F27Ethyl loflazepate.
F124Etizolam.
F30Fencamfamin.
F30Fenethylline.
F30Fenproporex.
F137Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).
F125Flubromazepam (7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine).
F27Fludiazepam.
F27Flunitrazepam.
F138Flunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).
F27Flurazepam.
F126Fonazepam (5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
F143...
F27Halazepam.
F27Haloxazolam.
F144...
F1273-Hydroxyphenazepam (7-Bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
F92...
F27Ketazolam.
F99Khat.
F27Loprazolam.
F27Lorazepam.
F27Lormetazepam.
F27Mazindol.
F128Meclonazepam (5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
F27Medazepam.
F30Mefenorex.
F33...
Mephentermine.
F27Meprobamate.
F28Mesocarb
F34...
F27Methyprylone.
F129Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine).
F35Midazolam.
F130Nifoxipam (5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2- one)
F27Nimetazepam.
F27Nitrazepam.
F131Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).
F146Nitrous oxide.
F27Nordazepam.
F139Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
F27Oxazepam.
F27Oxazolam.
F36Pemoline.
F33...
Phendimetrazine.
F27Phentermine.
F27Pinazepam.
F33...
F83...
F27Prazepam.
F132Pyrazolam (8-Bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine).
F33...
F37...
F30Pyrovalerone.
F160Remimazolam.
F27Temazepam.
F27Tetrazepam.
F93Tramadol.
F27Triazolam.
F30N-Ethylamphetamine.
F94Zaleplon.
F42Zolpidem
F95Zopiclone.
F38b
F585α–Androstane–3,17–diol.
F59Androst-4-ene-3,17-diol.
F601–Androstenediol.
F611–Androstenedione
F434-Androstene-3, 17-dione
F625–Androstenedione.
F435-Androstene-3, 17-diol
Atamestane.
Bolandiol.
Bolasterone.
Bolazine.
Boldenone.
F63Boldione.
Bolenol.
Bolmantalate.
F145...
Calusterone.
4-Chloromethandienone.
Clostebol.
F64Danazol.
F65Desoxymethyltestosterone
F105Dienedione (estra-4, 9-diene-3,17-dione).
Drostanolone.
Enestebol.
Epitiostanol.
Ethyloestrenol.
Fluoxymesterone.
Formebolone.
Furazabol.
F134Gabapentin (1-(aminomethyl)cyclohexaneacetic acid).
F66Gestrinone.
F673–Hydroxy–5α–androstan–17–one.
Mebolazine.
Mepitiostane.
Mesabolone.
Mestanolone.
Mesterolone.
Methandienone.
Methandriol.
Methenolone.
Methyltestosterone.
Metribolone.
Mibolerone.
Nandrolone.
F6819–Norandrostenedione.
F4419-Nor-4-Androstene-3, 17-dione
F6919–Norandrosterone.
F4419-Nor-5-Androstene-3, 17-diol
Norboletone.
Norclostebol.
Norethandrolone.
F7019–Noretiocholanolone.
F71Oripavine.
Ovandrotone.
Oxabolone.
Oxandrolone.
Oxymesterone.
Oxymetholone.
F84Pipradrol.
Prasterone.
F135Pregabalin ((S)-3-(aminomethyl)-5-methylhexanoic acid).
Propetandrol.
F72Prostanozol
Quinbolone.
Roxibolone.
Silandrone.
Stanolone.
Stanozolol.
Stenbolone.
Testosterone.
F73Tetrahydrogestrinone.
Thiomesterone.
Trenbolone.
c
any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,
i
by further substitution at position 17 by a methyl or ethyl group;
ii
by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
iii
by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;
iv
by fusion of ring A with a heterocyclic system;
F74ca
1–benzylpiperazine or any compound structurally derived from 1–benzylpiperazine or 1–phenylpiperazine by modification in any of the following ways—
i
by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;
ii
by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups.
d
any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above F56...;
e
2
Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule F39not being phenylpropanolamine.
3
Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.
4
Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.
Part IV Meaning of certain Expressions used in this Schedule
For the purposes of this Schedule the following expressions (which are not among those defined in section 37(1) of this Act) have the meanings hereby assigned to them respectively, that is to say—
“cannabinol derivatives” means the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives;
“coca leaf” means the leaf of any plant of the genusErythroxylonfrom whose leaves cocaine can be extracted either directly or by chemical transformation;
“concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids;
F98“khat” means the leaves, stems or shoots of the plant of the species Catha edulis;
“medicinal opium” means raw opium which has undergone the process necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral substances;
“opium poppy” means the plant of the speciesPapaver somniferum L;
“poppy straw” means all parts, except the seeds, of the opium poppy, after mowing;
“raw opium” includes powdered or granulated opium but does not include medicinal opium.